Stay updated on Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial page.

Latest updates to the Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial page
- Check2 days agoChange DetectedThe rheumatoid arthritis study record is displayed, including its design, treatment arms, eligibility criteria, outcome measures, results-related publications, and data-sharing information.SummaryDifference100%

- Check9 days agoChange DetectedThe footer’s site revision changed from v3.7.2 to v3.8.0; the study record content remains unavailable.SummaryDifference0.2%

- Check23 days agoChange DetectedA site-wide NIH banner announces a website transition and terminology change from “Artificial Intelligence” to “Super Intelligence.” The site revision advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check37 days agoChange DetectedThe footer revision number changes from v3.7.0 to v3.7.1 on the page displaying a 403 Forbidden error.SummaryDifference0.2%

- Check51 days agoChange Detected- The study page now shows a 403 Forbidden error page, replacing the study record content. This change prevents viewing the trial details and related information, reflecting a blockage in accessing essential information on the page.SummaryDifference18%

- Check58 days agoChange DetectedFooter revision label updated from v3.6.6 to v3.7.0, indicating a version change of the page components.SummaryDifference0.0%

Stay in the know with updates to Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial page.